VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses.
第一作者:
Yilan,Shen
第一单位:
Department of Nephrology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
作者:
关键词
ACR, urine albumin-to-creatinine ratioADFP, adipocyte differentiation-related proteinAGEs, advanced glycation end productsALT, alanine aminotransferaseAST, aspartate aminotransferaseBUN, blood urea nitrogenCcr, creatinine clearance rateDN, diabetic nephropathyDiabetic nephropathyECM, extracellular matrixESRD, end-stage renal diseaseFA, fatty acidFATPs, fatty acid transport proteinsFusion proteinGBM, glomerular basement membraneGSEA, gene set enrichment analysisH&E, hematoxylin & eosinHbA1c, glycosylated hemoglobinIL-22, interleukin-22Interleukin-22KEGG, Kyoto Encyclopedia of Genes and GenomesNAC, N-acetyl-l-cysteineNLRP3, NOD-like receptor family pyrin domain-containing protein 3NRP-1, neuropilin-1PAS, periodic acid-SchiffROS, reactive oxygen speciesSDS-PAGE, SDS-polyacrylamide gel electrophoresisTEM, transmission electron microscopyVEGF-B, vascular endothelial growth factor BVEGFR, vascular endothelial growth factor receptorVascular endothelial growth factor BeGFR, estimated glomerular filtration rateβ2-MG, β2 microglobulin
DOI
10.1016/j.apsb.2020.07.002
PMID
33532185
发布时间
2021-02-06
- 浏览0

Acta pharmaceutica Sinica. B
2021年11卷1期
127-142页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文